State Street
NTUS

State Street’s Natus Medical Inc NTUS Stock Holding History

State Street’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,377,189
Closed -$45.1M – 5011
2022
Q2 		$45.1M Buy
1,377,189
+31,815
+2% +$1.01M ﹤0.01% 1713
2022
Q1 		$35.4M Buy
1,345,374
+26,928
+2% +$657K ﹤0.01% 1979
2021
Q4 		$31.3M Sell
1,318,446
-9,218
-0.7% -$228K ﹤0.01% 2145
2021
Q3 		$33.3M Sell
1,327,664
-40,609
-3% -$1.03M ﹤0.01% 2107
2021
Q2 		$35.5M Buy
1,368,273
+29,377
+2% +$799K ﹤0.01% 2099
2021
Q1 		$34.3M Buy
1,338,896
+22,696
+2% +$582K ﹤0.01% 2015
2020
Q4 		$26.4M Sell
1,316,200
-52,723
-4% -$1.03M ﹤0.01% 2069
2020
Q3 		$23.4M Sell
1,368,923
-28,407
-2% -$537K ﹤0.01% 1934
2020
Q2 		$30.5M Buy
1,397,330
+168,396
+14% +$3.85M ﹤0.01% 1776
2020
Q1 		$28.4M Buy
1,228,934
+44,371
+4% +$1.29M ﹤0.01% 1612
2019
Q4 		$39.1M Sell
1,184,563
-404
-0% -$12.9K ﹤0.01% 1683
2019
Q3 		$37.7M Sell
1,184,967
-91,494
-7% -$2.67M ﹤0.01% 1638
2019
Q2 		$32.8M Sell
1,276,461
-73,794
-5% -$1.88M ﹤0.01% 1761
2019
Q1 		$34.3M Buy
1,350,255
+207,426
+18% +$6.19M ﹤0.01% 1679
2018
Q4 		$38.9M Sell
1,142,829
-72,646
-6% -$2.36M ﹤0.01% 1515
2018
Q3 		$43.3M Buy
1,215,475
+151,687
+14% +$5.36M ﹤0.01% 1638
2018
Q2 		$36.7M Buy
1,063,788
+133,049
+14% +$4.66M ﹤0.01% 1704
2018
Q1 		$31.3M Buy
930,739
+38,495
+4% +$1.22M ﹤0.01% 1743
2017
Q4 		$34.1M Buy
892,244
+24,907
+3% +$994K ﹤0.01% 1699
2017
Q3 		$32.5M Buy
867,337
+10,761
+1% +$380K ﹤0.01% 1673
2017
Q2 		$31.9M Buy
856,576
+45,918
+6% +$1.66M ﹤0.01% 1660
2017
Q1 		$31.8M Buy
810,658
+63,493
+8% +$2.38M ﹤0.01% 1609
2016
Q4 		$26M Buy
747,165
+37,378
+5% +$1.47M ﹤0.01% 1706
2016
Q3 		$27.9M Buy
709,787
+41,412
+6% +$1.65M ﹤0.01% 1546
2016
Q2 		$25.3M Sell
668,375
-6,004
-0.9% -$201K ﹤0.01% 1591
2016
Q1 		$25.9M Buy
674,379
+14,617
+2% +$544K ﹤0.01% 1543
2015
Q4 		$31.7M Buy
659,762
+370
+0.1% +$17.1K ﹤0.01% 1417
2015
Q3 		$26M Buy
659,392
+4,809
+0.7% +$204K ﹤0.01% 1573
2015
Q2 		$27.9M Buy
654,583
+8,852
+1% +$353K ﹤0.01% 1641
2015
Q1 		$25.5M Buy
645,731
+25,212
+4% +$930K ﹤0.01% 1681
2014
Q4 		$22.4M Buy
620,519
+2,714
+0.4% +$91.2K ﹤0.01% 1723
2014
Q3 		$18.2M Sell
617,805
-16,768
-3% -$463K ﹤0.01% 1810
2014
Q2 		$16M Buy
634,573
+15,916
+3% +$394K ﹤0.01% 1959
2014
Q1 		$16M Buy
618,657
+17,612
+3% +$444K ﹤0.01% 1926
2013
Q4 		$13.5M Buy
601,045
+3,691
+0.6% +$71.3K ﹤0.01% 2018
2013
Q3 		$8.47M Buy
597,354
+5,985
+1% +$80K ﹤0.01% 2221
2013
Q2 		$8.07M Buy
+591,369
New +$8.06M ﹤0.01% 2177

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

State Street's NTUS Position: Q3 2022 in Review

State Street sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 1,377,189 shares — an estimated $45.1M sold.

State Street first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $45.1M in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • State Street reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • State Street sold 1,377,189 Natus Medical Inc shares in Q3 2022, an estimated $45.1M.
  • State Street first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
  • State Street's Natus Medical Inc position peaked at $45.1M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on State Street's 13F filing for Q3 2022, filed 15 Nov 2022.